ask="5.20"
ask_size="1000"
average_daily_volume="547798"
bid="4.41"
bid_size="300"
book_value="3.74"
change="+0.42"
change_from_200_day_moving_average="3.22"
change_from_50_day_moving_average="1.01"
change_from_52_week_high="-7.56"
change_From_52_week_low="0.86"
change_in_percent="+8.97%"
close="5.10"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-41.42M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.03"
ex_dividend_date="N/A"
float_shares="13385000"
high="5.24"
high_52_weeks="12.66"
last_trade_date="1/4/2017"
last_trade_price="5.10"
last_trade_size="13487"
last_trade_time="4:00pm"
low="4.65"
low_52_weeks="4.24"
market_capitalization="115.01M"
moving_average_200_day="1.88"
moving_average_50_day="4.09"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="4.73"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+171.81%"
percent_change_from_50_day_moving_average="+24.61%"
percent_change_from_52_week_high="-59.72%"
percent_change_from_52_week_low="+20.37%"
previous_close="4.68"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.25"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="5.06"
stock_exchange="NMS"
symbol="CASC"
volume="219749"
weeks_range_52="4.24 - 12.66"
